Ambrx Biopharma, Inc.

AMAMDelisted Mar 7, 2024

Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001990550

SEC filings (opens in a new tab)

Ambrx Biopharma, Inc. was delisted on Mar 7, 2024; its insiders filed their last Form 4 on Mar 7, 2024; 68 institutions reported holding it in 13F filings for Q4 2023, worth $912.7M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding Ambrx Biopharma, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of AMAM: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Q2 2022	Change
Holders	14	14	0
Shares	17.1M	17.1M	−18.9K (−0.1%)
Value	$70.6M	$45.4M	−$25.2M (−35.8%)

New holders (1)

Institutions that held Ambrx Biopharma, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to AMAM in Q2 2022
Institution	Shares	Value	% of portfolio
UBS Group AG	242	$1.00K	0.00%

Sold out (1)

Institutions that held Ambrx Biopharma, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of AMAM in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Morgan Stanley	2,800	$12.0K